CompoAtlas

ZBT 390 TN Capsule

ZBT 390 TN Capsule : Product registered in Malaysia. This registration does not constitute authorisation for sale in France or the European Union. It does not demonstrate the safety or efficacy of the product.

NPRA, Malaysian pharmaceutical products register, retrieved 27 October 2026.

Ministry of Health Malaysia / NPRA, Pharmaceutical Products, CC BY 4.0

CC BY 4.0

Registration number
MAL24116152TR
Type
Natural product
Published status
PRODUCT APPROVED
Licence holder
ZBT FAR EAST SDN. BHD.
Manufacturer
Yangling Buchang Pharmaceutical Co., Ltd.
Importer
ZBT FAR EAST SDN. BHD.
Registration period starting
2024-11-07
Published validity end
2029-11-07

The foreign register category does not determine the regulatory category of the product in France.

French and European references for recognised ingredients

No point flagged by the rules applied to recognised ingredients.

Unidentified ingredients are not assessed. The absence of a signal does not establish product compliance.

Published composition

Published ingredientPublished text and quantityIdentified nutrient or substance
Saposhnikovia divaricataSaposhnikovia divaricata[50 mg,400 mg]Not identified
Gastrodia elataGastrodia elata[150 mg,400 mg]Not identified
Buthus martensiiButhus martensii[30 mg,400 mg]Not identified
Saposhnikovia divaricataSaposhnikovia divaricata[130 mg,400 mg]Not identified
Gastrodia elataGastrodia elata[120 mg,400 mg]Not identified
Polygonum multiflorumPolygonum multiflorum[270 mg,400 mg]Not identified
Angelica sinensisAngelica sinensis[180 mg,400 mg]Not identified
Smilax glabraSmilax glabra[360 mg,400 mg]Not identified

The imported data provide no usable daily dosage. No daily dose is estimated and no comparison with dose limits is performed. A published quantity may refer to a preparation or an unspecified unit. Chinese names are retained without translation.

Original register data

View published fields and their variants
Active ingredients
Saposhnikovia divaricata[50 mg,400 mg],Gastrodia elata[150 mg,400 mg],Buthus martensii[30 mg,400 mg],Saposhnikovia divaricata[130 mg,400 mg],Gastrodia elata[120 mg,400 mg],Polygonum multiflorum[270 mg,400 mg],Angelica sinensis[180 mg,400 mg],Smilax glabra[360 mg,400 mg]
Valid until
2029-11-07
Registration date
2024-11-07
Published description
NATURAL PRODUCT
Licence holder
ZBT FAR EAST SDN. BHD.
Importer
ZBT FAR EAST SDN. BHD.
Producer
Yangling Buchang Pharmaceutical Co., Ltd.
Published name
ZBT 390 TN Capsule
Published reference
2024032914496T
Registration number
MAL24116152TR
Published status
PRODUCT APPROVED

Official source

View the official register, number MAL24116152TR

Ministry of Health Malaysia / NPRA, Pharmaceutical Products, CC BY 4.0

CC BY 4.0

Official warnings (Health Canada)

Health Canada publishes warnings on these ingredients:

  • Angelica sinensis
    Read the warning, when it applies and the studies cited

    DONG QUAI - ANGELICA SINENSIS

    Route of administration: Oral

    Cautions and warnings

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are breastfeeding (NS 2021).

    1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).

    Ask a health care practitioner/health care provider/health care professional/doctor/physician prior to use if you are taking any medications including blood thinners, birth control pills or hormone therapy (NS 2021; Brinker 2010; WHO 2002).

    3 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have serious or major conditions, any type of acute infection, deficiency or excess (HC 2022).

    1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).

    When using this product avoid exposure to the sun (NS 2021; Thorne 2004).

    2 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    Contraindications

    Do not use if you are pregnant (NS 2021; WHO 2002).

    2 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    Do not use if you have diarrhea, hemorrhagic diseases or heavy periods (NS 2021, Bensky et al. 2004; Chen and Chen 2004; WHO 2002).

    4 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    Known adverse reactions

    Stop use and ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen, or if new symptoms develop such as breast pain or any changes in menstrual cycles (Brinker 2010; Schumacher et al. 2007; Thorne 2004; Russell et al. 2002).

    4 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    Health Canada monograph dated 29 May 2026

They concern the ingredient, not this product or its dose. They do not replace medical advice.

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.

Enter to analyse, Shift+Enter for a new line